Protagenic Therapeutics, Inc.
PTIX
$1.80
-$0.10-5.03%
NASDAQ
| 09/30/2025 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.54% | -- | |||
| Total Receivables | -55.38% | -- | |||
| Inventory | 0.00% | -- | |||
| Prepaid Expenses | -32.94% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -34.01% | -- | |||
|
|
|||||
| Total Current Assets | -34.01% | -- | |||
| Net Property, Plant & Equipment | -19.69% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 0.00% | -- | |||
| Total Assets | -22.89% | -- | |||
|
|
|||||
| Total Accounts Payable | -21.22% | -- | |||
| Total Accrued Expenses | -19.34% | -- | |||
| Short-term Debt | -0.38% | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -5.27% | -- | |||
| Total Other Current Liabilities | -5.27% | -- | |||
| Total Current Liabilities | -7.25% | -- | |||
|
|
|||||
| Total Current Liabilities | -7.25% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -0.38% | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -7.25% | -- | |||
|
|
|||||
| Common Stock & APIC | 1.57% | -- | |||
| Retained Earnings | -8.32% | -- | |||
| Treasury Stock & Other | 14.33% | -- | |||
| Total Common Equity | -18.28% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -18.28% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -18.28% | -- | |||
|
|
|||||